|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


,1
* Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; and
Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang, China
1Correspondence: Department of Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD 21205, USA. E-mail: xfyu{at}jhsph.edu
APOBEC3 proteins are cellular antiviral proteins that are targeted for proteasomal degradation by primate lentiviral Vif proteins. Vif acts as a substrate receptor for the Cullin5 (Cul5) E3 ubiquitin ligase, specifically interacting with Cul5 through a novel H-x5-C-x17–18-C-x3–5-H zinc binding motif. Using the membrane-permeable zinc chelator, N,N,N',N'-tetrakis-(2-pyridylmethyl) ethylenediamine (TPEN), we demonstrated a requirement for zinc for Vif function in vivo. Treatment with TPEN at an IC50 of 1.79 µM inhibits Cul5 recruitment and APOBEC3G (A3G) degradation. Zinc chelation prevented Vif function in infectivity assays, allowing the virus to become sensitive to the antiviral activity of A3G. Zinc chelation had no effect on cellular Cul5-SOCS3 E3 ligase assembly, suggesting that zinc-dependent E3 ligase assembly may be unique to HIV-1 Vif, representing a new target for novel drug design.—Xiao, X., Ehrlich, E., Luo, K., Xiong, Y., Yu, X-F. Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G.
Key Words: HIV-1 virion lentiviral Vif proteins TPEN zinc binding motif
This article has been cited by other articles:
![]() |
S. K. Gandhi, J. D. Siliciano, J. R. Bailey, R. F. Siliciano, and J. N. Blankson Role of APOBEC3G/F-Mediated Hypermutation in the Control of Human Immunodeficiency Virus Type 1 in Elite Suppressors J. Virol., March 15, 2008; 82(6): 3125 - 3130. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, C. Tian, W. Zhang, K. Luo, P. T. N. Sarkis, L. Yu, B. Liu, Y. Yu, and X.-F. Yu 7SL RNA Mediates Virion Packaging of the Antiviral Cytidine Deaminase APOBEC3G J. Virol., December 1, 2007; 81(23): 13112 - 13124. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Russell and V. K. Pathak Identification of Two Distinct Human Immunodeficiency Virus Type 1 Vif Determinants Critical for Interactions with Human APOBEC3G and APOBEC3F J. Virol., August 1, 2007; 81(15): 8201 - 8210. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |